Reata draws Buy rating at Goldman on potential for neuromuscular disease therapy
25 March 2022 - 1:29AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Apr 2024 to May 2024
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From May 2023 to May 2024